The role of Bordetella pertussis in the development of multiple sclerosis

Mohammad Mahdi Majzoobi1,2, Mohammad Reza Macvandi1, Hamidreza Ghasemi Basir3

  • 1Department of Infectious Diseases, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

BMC Neurology
|March 2, 2022
PubMed
Abstract

Insights

This study found no significant difference in Bordetella pertussis antibody levels or nasopharyngeal colonization rates between multiple sclerosis patients and healthy controls. These findings suggest B. pertussis may not play a role in multiple sclerosis development.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Multiple sclerosis (MS) is a common neurological disorder with an unidentified cause.
  • Infectious agents, including Bordetella pertussis (B. pertussis), have been implicated in MS pathogenesis.
  • Asymptomatic nasopharyngeal colonization by B. pertussis is a potential route of infection.

Purpose of the Study:

  • To compare serum B. pertussis antibody levels in MS patients and controls.
  • To investigate and compare nasopharyngeal colonization rates of B. pertussis in MS patients and controls.
  • To evaluate the potential role of B. pertussis in the development of MS.

Main Methods:

  • A case-control study involving 109 MS patients and 114 healthy controls.
  • Serum B. pertussis antibody titers were measured.
  • Nasopharyngeal colonization was assessed using culture and real-time PCR.

Main Results:

  • No significant difference in serum B. pertussis antibody titers between MS patients (37.8%) and controls (35.1%).
  • B. pertussis nasopharyngeal colonization was not detected in either group by culture or real-time PCR.
  • Statistical analysis showed no correlation between B. pertussis and MS.

Conclusions:

  • B. pertussis antibody titers and nasopharyngeal colonization rates do not differ between MS patients and healthy individuals.
  • The study suggests B. pertussis is unlikely to be a causative agent in the development of multiple sclerosis.
  • Further research may be needed to explore other potential infectious triggers for MS.